<DOC>
	<DOCNO>NCT02892305</DOCNO>
	<brief_summary>The goal study evaluate describe surgical overall outcome subject undergo pancreatectomy hepatic resection/ablation pancreatic cancer low-volume hepatic metastasis , part routine care . Subjects follow determine operative risk 90-day morbidity mortality . In addition , survival outcome compare historical control undergo surgery . Secondary outcome include mortality morbidity ; operative time ; blood loss transfusion requirement ; oncologic outcome : margin status , lymph node harvest , disease-free survival , overall survival . Analysis subject tumor characteristic help investigator identify subject would benefit aggressive multimodal approach .</brief_summary>
	<brief_title>Hepatic Resection Metastatic Pancreatic Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>least 18 year age least minimum Age Majority accord applicable State Country Law candidate surgery , ( i.e. , able undergo general anesthesia surgical resection diagnosis cancer ) willing able cooperate survey participation suitable candidate surgical intervention blindness speak read English pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pancreaticoduodenectomy</keyword>
	<keyword>Hepatectomy</keyword>
	<keyword>Liver ablation</keyword>
</DOC>